Intranasal Dexmedetomidine vs Midazolam-ketamine Combination for Premedication of Pediatric Patients
NCT ID: NCT02072083
Last Updated: 2015-04-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
60 participants
INTERVENTIONAL
2014-02-28
2014-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hydroxyzine Dihydrochloride Premedication is a Necessity for Strabismus Surgery
NCT03806270
Effect of Dexmedetomedine in Subtenon's Block on Emergence Agitation in Pediatric Strabismus Surgery
NCT04485273
Effects of Dexmedetomidine Premedication on Emergence Agitation After Strabismus Surgery in Children
NCT01895023
Intravenous Versus Peribulbar Dexmedetomidine for Strabismus Surgery in Adults
NCT05215158
The Effects of Dexmedetomidine on Early Stage Renal Functions in Pediatric Patients
NCT01948336
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
dexmedetomidine
intranasal 1mcg/kg
Dexmedetomidine
via intranasal route 1 mcg/kg
ketamine
intranasal 7,5 mg/kg ketamine and 0,1 mg/kg midazolam
Ketamine
via intranasal route 7,5 mg/kg ketamine and 0,1 mg/kg midazolam
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dexmedetomidine
via intranasal route 1 mcg/kg
Ketamine
via intranasal route 7,5 mg/kg ketamine and 0,1 mg/kg midazolam
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* the pediatric patients between 2-11 years old
* ASA physical status I-II
* the patients whose parents give permission for this study
Exclusion Criteria
* mental retardation
* cardiac arrhythmia or congenital cardiac disease
* organ disfunction (liver , kidney)
* nasal pathology
* psychotropic treatment
2 Years
11 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
TC Erciyes University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
müge yüce yıldırım
resident
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Müge Yüce Yıldırım, resident
Role: PRINCIPAL_INVESTIGATOR
erciyes univercity
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Erciyes university hospital
Kayseri, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013/381
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.